Format

Send to

Choose Destination
Expert Rev Vaccines. 2007 Aug;6(4):559-78.

Improving vaccines by incorporating immunological coadjuvants.

Author information

1
Experimental Therapeutics Laboratory, Hanson Institute, and School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Australia. cara.fraser@imvs.sa.gov.au

Erratum in

  • Expert Rev Vaccines. 2007 Dec;6(6):1022.

Abstract

While vaccination continues to be the most successful interventionist health policy to date, infectious disease remains a significant cause of death worldwide. A primary reason that vaccination is not able to generate effective immunity is a lack of appropriate adjuvants capable of initiating the desired immune response. Adjuvant combinations can potentially overcome this problem; however, the possible permutations to consider, which include the route and kinetics of vaccination, as well as combinations of adjuvants, are practically limitless. This review aims to summarize the current understanding of adjuvants and related immunological processes and how this knowledge can and has been applied to the strategic selection of adjuvant combinations as components of vaccines against human infectious disease.

PMID:
17669010
DOI:
10.1586/14760584.6.4.559
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center